Leonteq Securities AG (Guernsey Branch) Stock

Certificat

XNLLTQ

CH1283534134

Market Closed - Swiss Exchange 11:15:00 2024-05-31 EDT
97.55 CHF +1.47% Intraday chart for Leonteq Securities AG (Guernsey Branch)
Current month-1.23%
1 month-1.23%
Date Price Change
24-05-31 97.55 +1.47%
24-05-29 96.14 -0.77%
24-05-27 96.89 -0.47%
24-05-24 97.35 +0.15%
24-05-23 97.2 -0.82%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 11:15 am

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer LEONTEQ
XNLLTQ
ISINCH1283534134
Date issued 2023-07-27
Strike 272.4 CHF
Maturity 2025-01-27 (240 Days)
Parity 0.27 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 102 CHF
Lowest since issue 90.67 CHF
Spread 3.1 CHF
Spread %0.32%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
231 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.14%
Consensus
  1. Stock Market
  2. Certificates
  3. XNLLTQ Certificat